1Lin Yang Li-Ge Kuang Hua-Chuan Zheng Jin-Yi Li Dong-Ying Wu Su-Min Zhang Yan Xin No.4 Lab,Cancer Institute,The First Affiliated Hospital,China Medical University,Shenyang 110001,China Ying Chen Shen Yang Gynecology & Obstetrics Hospital,Shenyang 110014,China.PTEN encoding product:a marker for tumorigenesis and progression of gastric carcinoma[J].World Journal of Gastroenterology,2003,9(1):35-39. 被引量：127
2[1]Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH,Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R,Swedlund B, Teng DH, Tavtigian SV. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997; 15:356-362
3[2]Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J,Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC,Ittmarn M, Tycko B, Hibshoosh H, Wigler MH, Parsons R. PTEN,a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997; 275:1943-1947
4[3]Li DM, Sun H. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res 1997; 57:2124-2129
5[4]Cantley LC, Neel BG.New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci U S A 1999; 96: 4240-4245
6[5]Wu X, Senechal K, Neshat MS, Whang YE, Sawyers CL. The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway. Proc Natl Acad Sci U S A 1998; 95:15587-15591
7[6]Sun H, Lesche R, Li DM, Liliental J, Zhang H, Gao J, Gavrilova N, Mueller B, Liu X, Wu H. PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,trisphosphate and Akt/protein kinase B signaling pathway.Proc Natl Acad Sci U S A 1999; 96:6199-6204
8[7]Maehama T, Taylor GS, Dixon JE. PTEN and myotubularin: novel phosphoinositide phosphatases.Annu Rev Biochem 2001; 70: 247-279
9[8]Besson A, Robbins SM, Yong VW. PTEN/MMAC1/TEP1 in signal transduction and tumorigenesis. Eur J Biochem 1999; 263: 605-611
10[9]Waite KA, Eng C. Protean PTEN: form and function. Am J Hum Genet 2002; 70:829-844
2Li J,Yen C,Liaw D,et al.PTEN:a putative protein tyrosine phosphatase gene mutated in human brain,breast,and prostate cancer[J].Science,1997,275(5308):1943-1947.
3Wikman H,Lamszus K,Detels N,et al.Relevance of PTEN loss in brain metastasis formation in breast cancer patients [J].Breast Cancer Res,2012,14(2):R49.DOI:10.1186/bcr3150.
4Noro R,Gemma A,Miyanaga A,et al.PTEN inactivation in lung cancer cells and the effect of its recovery on treatment with epidermal growth factor receptor tyrosine kinase inhibitors[J].Int J Oncol,2007,31(5):1157-1163.
5Kokkinos M I,Wafai R,Wong M K,et al.Vimentin and epithelial-mesenchymal transition in human breast cancer--observations in vitro and in vivo[J].Cells Tissues Organs,2007,185(1/3):191-203.
6Lorusso G,Ruegg C.The tumor microenvironment and its contribution to tumor evolution toward metastasis[J].Histochem Cell Biol,2008,130(6):1091-1103.
7Thiery J P,Acloque H,Huang R Y,et al.Epithelial-mesenchymal transitions in development and disease[J].Cell,2009,139(5):871-890.DOI:10.1016/j.cell.2009.11.007.
8Ansieau S,Courtois-Cox S,Morel A P,et al.Failsafe program escape and EMT:A deleterious partnership[J].Semin Cancer Biol,2011,21(6):392-396.DOI:10.1016/j.semcancer.2011.09.014.
9Zhang H Y,Wang Z Q,Li Y Y,et al.Transforming growth factor-β1-induced epithelial-mesenchymal transition in human esophageal squamous cell carcinoma via the PTEN/PI3K signaling pathway[J].Oncol Rep,2014,32(5):2134-2142.DOI:10.3892/or.2014.3453.
10Xie R,Xu J,Wen G,et al.The P2Y2 nucleotide receptor mediates the proliferation and migration of human hepatocellular carcinoma cells induced by ATP[J].J Biol Chem,2014,289(27):19137-19149.
